Details for Patent: 6,713,446
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 6,713,446 protect, and when does it expire?
Patent 6,713,446 protects VELCADE and is included in one NDA.
Protection for VELCADE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-seven patent family members in thirteen countries.
Summary for Patent: 6,713,446
Title: | Formulation of boronic acid compounds |
Abstract: | The present invention provides stable compounds prepared from boronic acid and lyophilized compounds thereof of the formula (1): ##STR1## in which Z.sup.1 and Z.sup.2 are moieties derived from sugar. The invention also provides methods for preparing such compounds. Lyophilizing a mixture comprising a boronic acid compound and a moiety derived from sugar produces a stable composition that readily releases the boronic acid compound upon reconstitution in aqueous media. |
Inventor(s): | Gupta; Shanker Lal (Rockville, MD) |
Assignee: | The United States of America as represented by the Secretary of the Department of Health and Human Services (Washington, DC) |
Application Number: | 10/056,567 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,713,446 |
Patent Claim Types: see list of patent claims | Compound; Use; Composition; |
Drugs Protected by US Patent 6,713,446
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | VELCADE | bortezomib | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 021602-001 | May 13, 2003 | AP | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,713,446
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 501157 | See Plans and Pricing | |||
Australia | 2002243646 | See Plans and Pricing | |||
Canada | 2435124 | See Plans and Pricing | |||
Canada | 2435146 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |